跳至主要内容
临床试验/EUCTR2009-010367-17-GB
EUCTR2009-010367-17-GB进行中(未招募)不适用

/A - DAMI

niversity of Dundee0 个研究点目标入组 80 人开始时间: 2009年5月29日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Confirmed diagnosis of myocardial infarction, based on the recently published Universal criteria for diagnosis of myocardial infarction (Troponin T >0.02 plus one of: Symptoms consistent with myocardial ischaemia, ECG changes consistent with myocardial ischaemia, new Q waves on ECG, new regional wall motion abnormality or evidence of new loss of viable myocardium on imaging.
  • Admitted to Tayside Hospitals within 1 week of index event
  • Age>18 years
  • Minimum of 6 weeks after index event
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Estimated GFR <40 ml/min (using the MDRD4 method)
  • Adjusted serum calcium <2.15mmol/L or >2.60 mmol/L
  • LFTs >3x upper limit of normal
  • Already taking vitamin D supplements. Consumption of fish oils will not be a contraindication to enrolment
  • Known metastatic malignancy
  • History of renal calculi or sarcoidosis
  • Supine systolic BP <80 mmHg
  • Pregnant, lactating, or of childbearing age and not taking reliable contraception
  • Unable to give written informed consent

研究者

发起方
niversity of Dundee

相似试验